Effect of total hip arthroplasty on brake reaction time and braking force.


Journal

Hip international : the journal of clinical and experimental research on hip pathology and therapy
ISSN: 1724-6067
Titre abrégé: Hip Int
Pays: United States
ID NLM: 9200413

Informations de publication

Date de publication:
Jan 2022
Historique:
pubmed: 24 6 2020
medline: 14 1 2022
entrez: 24 6 2020
Statut: ppublish

Résumé

The correct moment for return to driving after total hip arthroplasty (THA) remains unclear. Until today no uniform recommendation exists on the ability to perform an emergency brake.The aim of this prospective study was to investigate the braking ability of patients before and after THA implantation based on brake reaction time in milliseconds (BRT) and braking force in N (BF). In total, 25 patients (15 men, 10 women, mean age 51.3 ± 10.1 years) were treated with THA on the right side. Inclusion criteria consisted of a valid driving licence, frequent road participation and at least 2 years of driving experience. Exclusion criteria were underlying neurological disorders as well as severe complaints in the lumbar spine and the right knee joint. The brake ability was evaluated for emergency braking with a car simulator and a measuring sole. Measurements were performed preoperatively, 6 days, 2, 4 and 6 weeks after surgery. Preoperatively, the mean BRT was 671.3 ± 123.5 ms and the BF 455.4 ± 185.0 N. Significant differences were observed at 6 days and 2 weeks after surgery, (BRT 836.4 ± 219.7 ms, respectively, BRT 735.0 ± 186.7 ms, and BF 302.6 ± 154.9 N, respectively, BF 375.5 ± 149.3 N, The braking force is significantly reduced, and the brake reaction time is prolonged directly after surgery for at least 2 weeks. After 4 weeks, no statistically significant differences were measured, although special care should still be taken during return to activity.

Identifiants

pubmed: 32573263
doi: 10.1177/1120700020936635
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

51-55

Auteurs

Henrik C Bäcker (HC)

Center for Musculoskeletal Surgery, Charité Berlin, University Hospital Berlin, Berlin, Germany.

David Krüger (D)

Center for Musculoskeletal Surgery, Charité Berlin, University Hospital Berlin, Berlin, Germany.

Sophie Spies (S)

Center for Musculoskeletal Surgery, Charité Berlin, University Hospital Berlin, Berlin, Germany.

Carsten Perka (C)

Center for Musculoskeletal Surgery, Charité Berlin, University Hospital Berlin, Berlin, Germany.

Stephanie M Kirschbaum (SM)

Center for Musculoskeletal Surgery, Charité Berlin, University Hospital Berlin, Berlin, Germany.

Sebastian Hardt (S)

Center for Musculoskeletal Surgery, Charité Berlin, University Hospital Berlin, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH